The Board of Directors of Deepak Nitrite Limited approved the appointment of Lohit Shringi as Chief Executive Officer of its Advanced Intermediates Business during a meeting held on August 4, 2026. The appointment is effective immediately and designates Shringi as a permanent employee. This leadership change signals a strategic focus on the advanced intermediates segment, leveraging Shringi’s extensive background in specialty chemicals and global operations to drive growth in this business unit.

The decision was formalized pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The Board meeting commenced at 2:00 P.M. and concluded at 5:00 P.M. on August 4, 2026. There are no disclosed relationships between the appointee and the company’s directors.

Executive Profile

Lohit Shringi brings over 27 years of leadership experience spanning P&L management, business transformation, strategy execution, innovation, operations, and governance. His academic credentials include a B.E. (Electrical) from the University of Rajasthan, Jaipur; an MBA from the Management Development Institute, Gurgaon; and a Certificate in Advanced Leadership Development from the University of Virginia, US.

Prior to joining Deepak Nitrite Limited, Shringi served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. In that role, he led a global business with strategic oversight across commercial, operations, innovation, and supply chain functions across multiple international markets. Earlier in his career, he held multiple leadership positions at DuPont across various geographies and businesses, as well as roles at Wipro Peripherals Public Ltd in Bengaluru.

Key Appointment Details

Strategic Context

The appointment of a seasoned executive with specific expertise in specialty chemicals and global supply chains suggests Deepak Nitrite Limited intends to strengthen its competitive positioning in the advanced intermediates sector. Shringi’s prior experience leading global businesses at PCBL Chemical Limited and managing complex operations at DuPont aligns with the requirements for scaling high-value chemical intermediates. The immediate effectiveness of the role indicates an urgent need for strategic direction in this business vertical.

Deepak Nitrite Limited reported a consolidated net profit of ₹345.01 crore for the quarter ended June 30, 2026, surging 207% year-on-year from ₹112.25 crore in Q1FY25. The chemical manufacturer’s consolidated revenue from operations climbed 36% to ₹2,577.60 crore, up from ₹1,889.88 crore in the corresponding period last year. This significant profitability expansion signals strong operational leverage and pricing power in key segments, particularly Phenolics, which contributed ₹417.76 crore to pre-tax segment results.

The Board of Directors approved the unaudited financial results at a meeting held on August 4, 2026. The results were reviewed by the Audit Committee and comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deloitte Haskins & Sells LLP, the statutory auditors, issued a limited review report on both standalone and consolidated interim financial results, confirming no material misstatements were identified during their review under Standard on Review Engagements (SRE) 2410.

Standalone Financial Performance

On a standalone basis, Deepak Nitrite recorded a net profit of ₹64.71 crore in Q1FY26, compared to ₹30.29 crore in Q1FY25. Standalone revenue from operations increased 32% to ₹806.76 crore from ₹612.28 crore. Other income stood at ₹6.18 crore, down from ₹7.42 crore in the prior year quarter. Total expenses rose to ₹725.85 crore from ₹578.77 crore, largely due to higher cost of materials consumed (₹451.84 crore vs ₹364.08 crore) and increased power and fuel expenses (₹59.84 crore vs ₹56.87 crore). Basic and diluted earnings per share (EPS) were ₹4.74, compared to ₹2.22 in Q1FY25.

Consolidated Segment Analysis

The consolidated results highlight distinct performance across business segments. The Phenolics segment, which includes subsidiaries like Deepak Phenolics Limited, drove the majority of the growth with segment revenue reaching ₹1,775.05 crore, up from ₹1,303.96 crore in Q1FY25. Its pre-tax segment result jumped to ₹417.76 crore from ₹117.90 crore. The Advanced Intermediates segment reported revenue of ₹803.85 crore and a pre-tax segment result of ₹66.98 crore. Total segment assets grew to ₹9,464.64 crore from ₹8,014.01 crore, while total segment liabilities increased to ₹3,250.66 crore from ₹2,477.81 crore.

What the Numbers Show

The disproportionate rise in net profit (207%) compared to revenue growth (36%) indicates significant margin expansion. This is largely attributable to the Phenolics segment, where pre-tax profits more than tripled despite a 36% revenue increase. Additionally, government incentive income recognized in a subsidiary contributed ₹21.50 crore to consolidated revenue in Q1FY26, compared to ₹17.23 crore in Q1FY25, providing a supportive tailwind. Finance costs increased to ₹22.91 crore from ₹8.13 crore, reflecting higher borrowing or interest rates, yet this was fully offset by operational gains.